The first cell-based gene therapy for multiple myeloma has been approved by the US Food and Drug Administration. Approval of […]
The NICE has specifically recommended a triplet therapy comprised of Kyprolis (carfilzomib), lenalidomide and dexamethasone in order to treat previously […]
Being the second most common type of blood cancer, 5-6% of the world population is diagnosed with Multiple Myeloma every […]